Martin Nägelin
Hospitals have their own internal manufacturing departments that provide patients with required medical products. In particular, patients in intensive care units require special drugs, often with CMR substances (i.e. substances that are carcinogenic, mutagenic or toxic for reproduction), which must frequently be produced specifically for the patient concerned. However, the range of drugs produced in the hospital pharmacies is much larger, and includes the entire repertoire of solid, semi-solid or liquid forms of administration with ingredients that may likewise be very diverse, from simple alcohol-based disinfectant solutions to complex antibiotics or drugs containing cytostatic agents. The resulting requirements for the manufacturing departments are correspondingly tough and are increasingly becoming a focal point for the regulatory agencies.
Over decades, the situation has frequently developed that these hospital pharmacies function as suppliers for both public pharmacies and as direct internal suppliers for their own hospitals. However, most hospitals wish to separate public consumers from internal hospital customers. For example, pharmacies that function as so-called public pharmacies are installed in the entrance areas of the hospitals. The hospital pharmacy itself and the drug-dispensing station are thus frequented only by the nursing staff. Material flows and personnel workflows must adapt to these requirements.